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A Martian meteorite, 1 magnetic inks,2 drug targeting, batteries,
contrasts for MRI, data storage or even clinical thermo-therapy3,4
seem to have no connection, but all have in common a dark mineral
called magnetite. However, in each of these applications this iron
oxide shows up with different forms because their optical, electri-
cal and magnetic properties are strongly dependent on size, shape
and kind of surfactant. In this sense the control of this character-
istics has long been of scientific and technological interest. In an
AC magnetic field-assisted cancer therapy, e.g., from a biological
point of view, the interaction of the nanoparticles with cells is crit-
ically determined by the surface properties which control their fate
in biological environments.5 Besides the size, factors as the shape
also seems to affect the cellular uptake.6–10 On the other hand,
the specific absorption rate (SAR) at a fixed frequency and mag-
netic field, is hugely dependent on average and distribution of size,
shape, crystalline anisotropy, and degree of aggregation or agglom-
eration of the nanoparticles. 11,12 Each of these factors contributes
to an independent energy loss mechanism: Néel relaxation, Brown
relaxation or magnetic hysteresis loss.13 Thus, the key for improv-
ing the efficiency of a given application is the knowledge about the
morphological control.
In this sense we synthesized magnetite nanoparticles via typical
thermal decomposition method. We used 4 mmol of Fe(acac)3 as a
precursor, 20 ml of benzyl ether as a solvent and for the first layer of
surfactant a mix of 8 mmol of oleic acid and (0, 4, 8, 12, 16) mmol
of oleylamine. 14,15 Each sample was desoxigened at room temper-
ature for 30 minutes, then heated to 295 °C at a rate of approxi-
mately 10 °C/min, keeping at that temperature for 30 minutes and
then cooled to room temperature. The entire process was carried
out in a nitrogen atmosphere. In the second step the final product
of the synthesis was washed several times with hexane and alcohol
and dispersed in an organic solvent. Then, the nanoparticles were
dispersed in an aqueous medium through the second coating with
lauric acid which shows good results of intracellular uptake.16 At
the end of this process we obtained ferrofluids in aqueous medium
at physiological pH and high concentrations of about 9.9 mg/ml
of Fe3O4. Therewith we synthesized nanoparticles in a range of
6.5± 0.1 - 176± 2 nm, as shown in figure 1, only variating the
quantity of oleylamine. The size distribution is shown in figure
2. The size reduction may be related to the increased of the ratio
surfactant/precursor, but is remarkable the fact that a small change
in the added mass of oleylamine can result in a large variation of
size. Another interesting result is the shape modification which is
attributed to the type of the first coating. There has being previously
reported that the type of the functional group of the surfactant de-
termine the final shape of the nanoparticles. 17 The capping reagent
can selectively adsorb on some particular facets, but the quantita-
tive result of a mixture has not yet been reported. However, same
works explores the growth of the polyhedral form as a function of
the surface energy, γhkl , where the results agree with ours.18
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Figure 1. TEM (a) and SEM (b) images of truncated octahedron of Fe3O4
nanoparticles synthesized without oleylamine (υ = 0), with 176 nm approx-
imately. Figures (c) and (d) show a mix of octahedron and cube nanopar-
ticles of 63, 29 prepared with 4 and 8 mmol respectively. Increasing the
amount of oleylamine to 12 and 16 mmol result in spherical-like nanoparti-
cles with 17 (e) and 6.5 nm (f).
The oleic acid with carboxylic group, -COOH, has a selective
binding onto the {111} crystal facets and oleylamine with a -NH2
group has a weak and unselective binding onto the surface which
leads to more spherical particles.19 It is also known that at a low
heating rate, preferential anisotropic growth along the kinetically
most favorable direction, but according to the classical theory, a
variation on the surface energy caused by the surfactant is dominant
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to fluctuations in temperature and saturation.20,21
Thereby, we define a shape factor parameter, υ , relating the
amount of oleic acid and oleylamine surfactants which bind dif-
ferently onto crystal facets.
υ ≡ noleylamine
noleic acid
{
> 0 : 2/♦→#
= 0 : 7 , (1)
where noleylamine and noleic acid are the number of mols of oley-
lamine and oleic acid respectively. When υ = 0 the favorable
growth direction is the {111} because there is only oleic acid and
when added oleylamine, υ > 0, the shape became a mix of cubes
and octahedrons until it becomes spherical with the increase of this
shape factor. A linear relationship between the diameter and the
Figure 2. Size as a function of the ratio of surfactant and precursor. The
surfactant contribution is expressed by shape factor υ defined in equation
??. The right side shows the distribution of size. The gray line is the best fit
and is express by the equation ??.
surfactant/precursor ratio is shown in figure 2. The gray curve is a
best linear fitting obtained in a semi-log graph and is represented
mathematically in equation ?? as
d =
dwo
e6.5
υ
nP
, (2)
where d is the diameter of nanoparticles, dwo is the nanoparticle di-
ameter for a synthesis without oleylamine, 6.5 is a fitted parameter
and nP is the number of mol of the precursor.
To explore a potential biomedical application, we measure the
SAR of the nanoparticles with 29 nm average size, which is shown
in figure 3. The results point to a notable specific absorption rate for
Figure 3. Time-dependent temperature curves of nanoparticles with diam-
eter of 29 nm. The black points indicates when the AC magnetic field was
applied. The inset shows the linear dependence between the specific ab-
sorption rate and the radio-frequency used.
these magnetite nanoparticles 22–24 even at low frequencies, becom-
ing appropriate for thermoablation. 25 The Brown relaxation due
to the rotation of the particles against viscous forces of the liquid
medium is expect for this size, including Néel relaxation and the
magnetic hysteresis loss which is proportional to the size was en-
larged by the double-layer coating.12 The inset in figure 3 shows a
linear dependence between the SAR and the radio-frequency field
applied in a 20 mT magnetic field.
In summary, we synthesized nanoparticles of magnetite with
sizes along three orders of magnitude, solely modifying the amount
of a unselective binding surfactant which also leads to a shape con-
trol. We obtained a relationship between the morphology of the
nanoparticles and the ratio surfactant/precursor and we have found
an equation which treat this dependence including a shape param-
eter (υ) for this synthesis configuration. Finally, we have explored
a possible biomedical application of hyperthermia which proved to
be superior to those found in literature.
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